首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: implications for a novel mechanism of Tpl2 regulation.
【24h】

Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: implications for a novel mechanism of Tpl2 regulation.

机译:癌蛋白激酶Tpl2磷酸化NF-κB1/ p105:对Tpl2调控新机制的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The oncoprotein kinase Tpl2 plays an essential role in macrophage activation by the bacterial component lipopolysaccharide (LPS). In response to LPS stimulation, Tpl2 phosphorylates a downstream kinase, MEK1, leading to the activation of ERK signaling pathway. Recent studies demonstrate that the NF-kappaB1 precursor protein p105 functions as an inhibitor of Tpl2 and that the LPS-stimulated Tpl2 activation requires p105 degradation. However, how p105 inhibits the signaling function of Tpl2 is not completely understood. We show here that p105 does not inhibit the intrinsic kinase activity of Tpl2. When complexed with p105, Tpl2 remains catalytically active and uses p105 as a substrate. However, the p105-bound Tpl2 is unable to phosphorylate its physiological target, MEK1. These findings suggest that p105 functions as a competitive inhibitor of Tpl2 that blocks its access by MEK1.
机译:癌蛋白激酶Tpl2在细菌组分脂多糖(LPS)激活巨噬细胞中起着至关重要的作用。响应LPS刺激,Tpl2磷酸化下游激酶MEK1,从而导致ERK信号通路的激活。最近的研究表明,NF-κB1前体蛋白p105充当Tpl2的抑制剂,LPS刺激的Tpl2激活需要p105降解。然而,尚未完全理解p105如何抑制Tpl2的信号传导功能。我们在这里显示p105不会抑制Tpl2的固有激酶活性。当与p105复合时,Tp12保持催化活性并使用p105作为底物。但是,与p105结合的Tpl2无法磷酸化其生理靶标MEK1。这些发现表明,p105充当Tpl2的竞争性抑制剂,阻止MEK1对其的访问。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号